Veracyte (VCYT) Stock
Veracyte (VCYT) closed at $24.01 on Nov 16, 2026; its Tenet Score is 78 of 100 against 313 Healthcare peers.
5 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Previous close
- $24.01
- Nov 16, 2026
- Market cap
- $2.0B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- P/E
- 15.9×
- price ÷ earnings
- 52-week range
- 21.91 – 60.91
- low → high · as of close, Nov 13, 2026
- Tenet Score
- 78/100
- Strong · 313 Healthcare peers
Industry: Drugs
Veracyte Inc scores 78/100. Strong. Strongest on growth and value, trading at 16× earnings versus 313 Healthcare peers.
Tenet Score · vs sector
n=313Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ~ Buffett Quality
- ~ Piotroski F-Score
- ~ Munger Compounders
- ~ Magic Formula
- ✕ Graham Defensive
- ~ Quality Compounder
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prosta…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Aurinia Pharmaceuticals IncAUPH | 83 | $2.1B |
| Vera Therapeutics IncVERA | 42 | $2.0B |
| Recursion Pharmaceuticals IncRXRX | 53 | $2.0B |
| Harmony Biosciences Holdings IncHRMY | 81 | $2.0B |
| Maravai LifeSciences Holdings IncMRVI | 29 | $2.0B |
| Biocryst Pharmaceuticals Inc.BCRX | 73 | $2.0B |
| Agios Pharmaceuticals IncAGIO | 64 | $1.9B |
| Eton Pharmaceuticals IncETON | 47 | $1.8B |
| Certara IncCERT | 48 | $1.8B |
| Stoke Therapeutics IncSTOK | 51 | $1.7B |
Common questions
What sector and industry is Veracyte in?
Veracyte is in the Healthcare sector and the Drugs industry.
What is Veracyte's Tenet Score?
Veracyte's Tenet Score is 78 out of 100, ranked against 313 Healthcare peers as of Nov 13, 2026.




